AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 25176414 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 22
Study 21894446 — intervention group
Group type: EXPERIMENTAL
Intervention: Mediterranean diet (MedDiet)
Number of subjects: 20
Study 21894446 — intervention group
Group type: COMPARATOR
Intervention: Saturated fatty acid diet (SFA)
Number of subjects: 20
Study 21894446 — intervention group
Group type: COMPARATOR
Intervention: Low‐fat and high‐carbohydrate diet (CHO‐ALA)
Number of subjects: 20
Study 19581537 — intervention group
Group type: COMPARATOR
Intervention: GEM (standard treatment) 1,000 mg/m(2)/30 minutes
Number of subjects: 832
Study 19581537 — intervention group
Group type: EXPERIMENTAL
Intervention: GEM FDR 1,500 mg/m(2)/150 minutes
Number of subjects: 832
Study 19581537 — intervention group
Group type: EXPERIMENTAL
Intervention: GEMOX (GEM 1,000 mg/m(2)/100 minutes + oxaliplatin 100 mg/m(2)/day 2 every 14 days)
Number of subjects: 832
Study 17121785 — intervention group
Group type: EXPERIMENTAL
Intervention: 1.36% glucose
Number of subjects: 10
Study 17121785 — intervention group
Group type: EXPERIMENTAL
Intervention: 1.1% amino acid solution
Number of subjects: 10
Study 17121785 — intervention group
Group type: EXPERIMENTAL
Intervention: 3.86% glucose (conventional and biocompatible fluids)
Number of subjects: 10
Study 17121785 — intervention group
Group type: EXPERIMENTAL
Intervention: 3.86% glucose
Number of subjects: 10
Study 16312170 — intervention group
Group type: EXPERIMENTAL
Intervention: Segmental allergen challenge
Number of subjects: 9
Study 11996957 — intervention group
Group type: EXPERIMENTAL
Intervention: Pitavastatin 2 mg daily
Number of subjects: 240
Study 11996957 — intervention group
Group type: COMPARATOR
Intervention: Pravastatin 10 mg daily
Number of subjects: 240
Study 9583841 — intervention group
Group type: EXPERIMENTAL
Intervention: Usual diet (UD) with 1.2‐1.5 g protein/kg body wt
Number of subjects: 15
Study 9583841 — intervention group
Group type: EXPERIMENTAL
Intervention: Chicken diet (CD) with 1.2‐1.5 g protein/kg body wt
Number of subjects: 15
Study 9583841 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-protein diet (LPD) with 0.5‐0.8 g protein/kg body wt
Number of subjects: 15
Study 7539186 — intervention group
Group type: EXPERIMENTAL
Intervention: TURP (Transurethral Resection of the Prostate)
Number of subjects: 0
Study 7539186 — intervention group
Group type: COMPARATOR
Intervention: VLAP (Visual Laser Ablation of the Prostate)
Number of subjects: 0
Study 7539186 — intervention group
Group type: COMPARATOR
Intervention: Laser therapy (holmium and diode lasers)
Number of subjects: 0
Study 1509068 — intervention group
Group type: EXPERIMENTAL
Intervention: Compressed collagen foam plug placement
Number of subjects: 50
Study 1509068 — intervention group
Group type: COMPARATOR
Intervention: Control group (no plug)
Number of subjects: 50
Study 6732159 — intervention group
Group type: EXPERIMENTAL
Intervention: Cimetidine treatment (34 patients)
Number of subjects: 52
Study 6732159 — intervention group
Group type: COMPARATOR
Intervention: Control group (18 patients)
Number of subjects: 52
Study 30912409 — intervention group
Group type: EXPERIMENTAL
Intervention: Probiotic (Pearls IC©)
Number of subjects: 36
Study 30912409 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 36
Study 29371061 — intervention group
Group type: EXPERIMENTAL
Intervention: Theory-based lifestyle intervention (two in-depth counseling sessions, telephone counseling, behavioral podcasts, social media support)
Number of subjects: 400
Study 29371061 — intervention group
Group type: EXPERIMENTAL
Intervention: Theory-based lifestyle intervention
Number of subjects: 400
Study 29371061 — intervention group
Group type: COMPARATOR
Intervention: Standard care (monthly mailings and matched podcasts on non-weight related topics)
Number of subjects: 400
Study 29371061 — intervention group
Group type: COMPARATOR
Intervention: Standard care
Number of subjects: 400
Study 26017469 — intervention group
Group type: EXPERIMENTAL
Intervention: On-Pace group (continued pacemaker activity)
Number of subjects: 19
Study 26017469 — intervention group
Group type: COMPARATOR
Intervention: Off-Pace group (deactivated pacemaker function)
Number of subjects: 19
Study 24777973 — intervention group
Group type: EXPERIMENTAL
Intervention: Internet-based cognitive-behavioural intervention
Number of subjects: 72
Study 24777973 — intervention group
Group type: COMPARATOR
Intervention: Face-to-face cognitive-behavioural group intervention
Number of subjects: 72
Study 22412140 — intervention group
Group type: EXPERIMENTAL
Intervention: Salvage chemotherapy (SLC) plus best supportive care (BSC)
Number of subjects: 202
Study 22412140 — intervention group
Group type: COMPARATOR
Intervention: Best supportive care (BSC) alone
Number of subjects: 202
Study 22412140 — intervention group
Group type: EXPERIMENTAL
Intervention: Salvage chemotherapy (SLC)
Number of subjects: 202
Study 20151421 — intervention group
Group type: EXPERIMENTAL
Intervention: Sustained-release cytarabine
Number of subjects: 100
Study 20151421 — intervention group
Group type: EXPERIMENTAL
Intervention: Methotrexate
Number of subjects: 100
Study 20151421 — intervention group
Group type: COMPARATOR
Intervention: Sustained-release cytarabine (lumbar administration)
Number of subjects: 100
Study 20151421 — intervention group
Group type: COMPARATOR
Intervention: Sustained-release cytarabine (ventricular administration)
Number of subjects: 100
Study 20151421 — intervention group
Group type: COMPARATOR
Intervention: Methotrexate (lumbar administration)
Number of subjects: 100
Study 20151421 — intervention group
Group type: COMPARATOR
Intervention: Methotrexate (ventricular administration)
Number of subjects: 100
Study 17634781 — intervention group
Group type: EXPERIMENTAL
Intervention: 4-item screen for PTSD
Number of subjects: 398
Study 17634781 — intervention group
Group type: EXPERIMENTAL
Intervention: PTSD checklist (PCL-17)
Number of subjects: 398
Study 15677733 — intervention group
Group type: EXPERIMENTAL
Intervention: Positive airway pressure treatment after a minimum period of 8 weeks
Number of subjects: 16
Study 15677733 — intervention group
Group type: COMPARATOR
Intervention: Healthy subjects
Number of subjects: 16
Study 12062776 — intervention group
Group type: EXPERIMENTAL
Intervention: Dialectical Behavior Therapy (DBT)
Number of subjects: 23
Study 12062776 — intervention group
Group type: COMPARATOR
Intervention: Comprehensive Validation Therapy with 12-Step (CVT + 12S)
Number of subjects: 23
Study 12062776 — intervention group
Group type: EXPERIMENTAL
Intervention: Both treatments
Number of subjects: 23
Study 9416309 — intervention group
Group type: EXPERIMENTAL
Intervention: Glycerol administration
Number of subjects: 32
Study 7684524 — intervention group
Group type: EXPERIMENTAL
Intervention: Finasteride 5 mg
Number of subjects: 750
Study 7684524 — intervention group
Group type: EXPERIMENTAL
Intervention: Finasteride 1 mg
Number of subjects: 750
Study 7684524 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 750
Study 2879832 — intervention group
Group type: EXPERIMENTAL
Intervention: Clorazepate
Number of subjects: 189
Study 2879832 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 189
Study 29098340 — intervention group
Group type: EXPERIMENTAL
Intervention: Higher levels of alcohol intoxication under easy primary task conditions
Number of subjects: 0
Study 29098340 — intervention group
Group type: EXPERIMENTAL
Intervention: Increasing difficulty of the primary task
Number of subjects: 0
Study 29098340 — intervention group
Group type: COMPARATOR
Intervention: Hard primary task conditions
Number of subjects: 0
Study 27760666 — intervention group
Group type: EXPERIMENTAL
Intervention: Systematic retroperitoneal lymphadenectomy (SL)
Number of subjects: 3353
Study 25541942 — intervention group
Group type: EXPERIMENTAL
Intervention: Botulinum toxin A
Number of subjects: 60
Study 25541942 — intervention group
Group type: COMPARATOR
Intervention: Vehicle (normal saline)
Number of subjects: 60
Study 22096040 — intervention group
Group type: EXPERIMENTAL
Intervention: High-flux dialysis
Number of subjects: 166
Study 22096040 — intervention group
Group type: COMPARATOR
Intervention: Low-flux dialysis
Number of subjects: 166
Study 20414441 — intervention group
Group type: EXPERIMENTAL
Intervention: Structured educational intervention for pharmacists
Number of subjects: 57
Study 20414441 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 57
Study 17119962 — intervention group
Group type: EXPERIMENTAL
Intervention: Surgical treatment
Number of subjects: 634
Study 17119962 — intervention group
Group type: COMPARATOR
Intervention: Non-surgical intervention
Number of subjects: 634
Study 15990220 — intervention group
Group type: EXPERIMENTAL
Intervention: Solifenacin 5 or 10 mg
Number of subjects: 0
Study 15990220 — intervention group
Group type: COMPARATOR
Intervention: Tolterodine extended release (ER) 4 mg
Number of subjects: 0
Study 12619955 — intervention group
Group type: EXPERIMENTAL
Intervention: Avoidance of precipitating factors (viral infections, smoke, dust, cold food, cold air)
Number of subjects: 0
Study 12619955 — intervention group
Group type: EXPERIMENTAL
Intervention: Short acting beta agonists as needed for mild episodic asthma
Number of subjects: 0
Study 12619955 — intervention group
Group type: EXPERIMENTAL
Intervention: Bronchodilators with daily maintenance treatment (low dose inhaled steroids, cromolyn, oral theophylline, leukotriene antagonists) for mild persistent asthma
Number of subjects: 0
Study 12619955 — intervention group
Group type: EXPERIMENTAL
Intervention: Inhaled steroids with long acting beta agonists for moderate persistent asthma
Number of subjects: 0
Study 12619955 — intervention group
Group type: EXPERIMENTAL
Intervention: Inhaled steroids, long acting beta agonists with or without theophylline for severe persistent asthma
Number of subjects: 0
Study 12619955 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral prednisolone on alternate days if symptoms are not well controlled
Number of subjects: 0
Study 12619955 — intervention group
Group type: EXPERIMENTAL
Intervention: Cromolyn, short or long acting beta agonists, or leukotriene antagonists for exercise-induced bronchoconstriction
Number of subjects: 0
Study 12619955 — intervention group
Group type: EXPERIMENTAL
Intervention: Maintenance treatment for children with seasonal asthma starting 2 weeks in advance and continued throughout the season
Number of subjects: 0
Study 11263278 — intervention group
Group type: EXPERIMENTAL
Intervention: Acupuncture treatment
Number of subjects: 29
Study 8686404 — intervention group
Group type: EXPERIMENTAL
Intervention: Laparotomy (group A)
Number of subjects: 20
Study 8686404 — intervention group
Group type: EXPERIMENTAL
Intervention: Laparoscopy (group B)
Number of subjects: 20
Study 1578308 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin D supplementation (100, 200, or 400 IU/day)
Number of subjects: 256
Study 1578308 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin D supplementation (400 IU/day recommended)
Number of subjects: 256
Study 1578308 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin D supplementation (various dosages)
Number of subjects: 256
Study 1578308 — intervention group
Group type: COMPARATOR
Intervention: Northern infants
Number of subjects: 256
Study 3878070 — intervention group
Group type: EXPERIMENTAL
Intervention: Coronary bypass surgery
Number of subjects: 0
Study 3878070 — intervention group
Group type: COMPARATOR
Intervention: Medical therapy
Number of subjects: 0
Study 29548913 — intervention group
Group type: EXPERIMENTAL
Intervention: ZipFix sternal closure (n=168)
Number of subjects: 326
Study 29548913 — intervention group
Group type: COMPARATOR
Intervention: Conventional wire sternal closure (n=158)
Number of subjects: 326
Study 29548913 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall participants (n=326)
Number of subjects: 326
Study 30565412 — intervention group
Group type: EXPERIMENTAL
Intervention: Hypoxia training (FiO2 15%)
Number of subjects: 23
Study 30565412 — intervention group
Group type: COMPARATOR
Intervention: Normoxia training (FiO2 21%)
Number of subjects: 23
Study 24955900 — intervention group
Group type: EXPERIMENTAL
Intervention: Cefazolin
Number of subjects: 109
Study 24955900 — intervention group
Group type: COMPARATOR
Intervention: Vancomycin
Number of subjects: 109
Study 21971752 — intervention group
Group type: EXPERIMENTAL
Intervention: Electromyographic biofeedback training
Number of subjects: 45
Study 21971752 — intervention group
Group type: EXPERIMENTAL
Intervention: Electrical stimulation therapy
Number of subjects: 45
Study 21971752 — intervention group
Group type: COMPARATOR
Intervention: Home exercise
Number of subjects: 45
Study 20735271 — intervention group
Group type: EXPERIMENTAL
Intervention: RTS,S/AS01(E) coadministered with EPI vaccines at 0, 1, and 2 months (3 doses)
Number of subjects: 511
Study 20735271 — intervention group
Group type: EXPERIMENTAL
Intervention: RTS,S/AS01(E) coadministered with EPI vaccines at 0, 1, and 7 months (2 doses)
Number of subjects: 511
Study 20735271 — intervention group
Group type: COMPARATOR
Intervention: EPI vaccines only
Number of subjects: 511
Study 18834461 — intervention group
Group type: EXPERIMENTAL
Intervention: Atrial synchronous ventricular pacing (VDD)
Number of subjects: 12
Study 18834461 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 12
Study 11890188 — intervention group
Group type: EXPERIMENTAL
Intervention: Olanzapine
Number of subjects: 2335
Study 10194773 — intervention group
Group type: EXPERIMENTAL
Intervention: Cisplatin
Number of subjects: 12
Study 7995745 — intervention group
Group type: EXPERIMENTAL
Intervention: Custom-made hemibody foam cradle (immobilization device)
Number of subjects: 74
Study 7995745 — intervention group
Group type: COMPARATOR
Intervention: No immobilization device (control group)
Number of subjects: 74
Study 2179284 — intervention group
Group type: EXPERIMENTAL
Intervention: metoprolol CR/ZOK 50 mg
Number of subjects: 195
Study 2179284 — intervention group
Group type: COMPARATOR
Intervention: atenolol 50 mg
Number of subjects: 195
Study 2179284 — intervention group
Group type: EXPERIMENTAL
Intervention: metoprolol CR/ZOK 100 mg
Number of subjects: 195
Study 2179284 — intervention group
Group type: COMPARATOR
Intervention: atenolol 100 mg
Number of subjects: 195
Study 2179284 — intervention group
Group type: EXPERIMENTAL
Intervention: metoprolol CR/ZOK
Number of subjects: 195
Study 2179284 — intervention group
Group type: COMPARATOR
Intervention: atenolol
Number of subjects: 195
Study 367510 — intervention group
Group type: EXPERIMENTAL
Intervention: Cytotoxic treatment
Number of subjects: 0
Study 367510 — intervention group
Group type: COMPARATOR
Intervention: Endocrine treatment
Number of subjects: 0
Study 29489714 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined balance and plyometric training (E) for 8 weeks
Number of subjects: 26
Study 29489714 — intervention group
Group type: COMPARATOR
Intervention: Control group (C) maintained normal basketball training schedule
Number of subjects: 26
Study 31479846 — intervention group
Group type: EXPERIMENTAL
Intervention: Yoga exercise intervention (8 weeks, twice a week instructor-led and once a week home practice)
Number of subjects: 40
Study 31479846 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 40
Study 27225016 — intervention group
Group type: EXPERIMENTAL
Intervention: Ottawa Model for Smoking Cessation
Number of subjects: 1367
Study 25854017 — intervention group
Group type: EXPERIMENTAL
Intervention: Prior-to-catheter acupuncture intervention (5 times per week for one month)
Number of subjects: 53
Study 25854017 — intervention group
Group type: COMPARATOR
Intervention: Both groups (prior-to-catheter and posterior-to-catheter)
Number of subjects: 53
Study 24237100 — intervention group
Group type: EXPERIMENTAL
Intervention: Chiropractic care including spinal manipulative therapy and massage
Number of subjects: 52
Study 20488404 — intervention group
Group type: COMPARATOR
Intervention: Early ISA in BMS
Number of subjects: 1580
Study 20488404 — intervention group
Group type: COMPARATOR
Intervention: Early ISA in TAXUS
Number of subjects: 1580
Study 20488404 — intervention group
Group type: COMPARATOR
Intervention: Late-acquired ISA in BMS
Number of subjects: 1580
Study 20488404 — intervention group
Group type: COMPARATOR
Intervention: Late-acquired ISA in TAXUS
Number of subjects: 1580
Study 20488404 — intervention group
Group type: COMPARATOR
Intervention: Late-acquired ISA in TAXUS slow-release
Number of subjects: 1580
Study 18478575 — intervention group
Group type: EXPERIMENTAL
Intervention: MRI examination
Number of subjects: 23
Study 16148848 — intervention group
Group type: EXPERIMENTAL
Intervention: RIX4414 (10^4.7 ffu)
Number of subjects: 2155
Study 16148848 — intervention group
Group type: EXPERIMENTAL
Intervention: RIX4414 (10^5.2 ffu)
Number of subjects: 2155
Study 16148848 — intervention group
Group type: EXPERIMENTAL
Intervention: RIX4414 (10^5.8 ffu)
Number of subjects: 2155
Study 16148848 — intervention group
Group type: EXPERIMENTAL
Intervention: RIX4414 (pooled vaccine groups)
Number of subjects: 2155
Study 16148848 — intervention group
Group type: EXPERIMENTAL
Intervention: RIX4414 (post-dose 1 to 14 days post-dose 2)
Number of subjects: 2155
Study 16148848 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 2155
Study 12548268 — intervention group
Group type: EXPERIMENTAL
Intervention: In-person triage without knowledge of vital signs
Number of subjects: 201
Study 12548268 — intervention group
Group type: EXPERIMENTAL
Intervention: In-person triage with knowledge of vital signs
Number of subjects: 201
Study 11020919 — intervention group
Group type: EXPERIMENTAL
Intervention: Speech therapy with active participation of mothers
Number of subjects: 0
Study 11020919 — intervention group
Group type: COMPARATOR
Intervention: Speech therapy without active participation of mothers (control group)
Number of subjects: 0
Study 8543554 — intervention group
Group type: EXPERIMENTAL
Intervention: Sertraline (mean dose 87 mg/day)
Number of subjects: 32
Study 8543554 — intervention group
Group type: COMPARATOR
Intervention: Desipramine (mean dose 110 mg/day)
Number of subjects: 32
Study 1805284 — intervention group
Group type: EXPERIMENTAL
Intervention: Aspartame chocolate drink (80 mg)
Number of subjects: 0
Study 1805284 — intervention group
Group type: COMPARATOR
Intervention: Sucrose chocolate drink (50 g)
Number of subjects: 0
Study 1805284 — intervention group
Group type: COMPARATOR
Intervention: Fasting
Number of subjects: 0
Study 6139364 — intervention group
Group type: EXPERIMENTAL
Intervention: Triazolam
Number of subjects: 53
Study 6139364 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 53
Study 29313803 — intervention group
Group type: EXPERIMENTAL
Intervention: Doxycycline (3-week course)
Number of subjects: 0
Study 29313803 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 27040594 — intervention group
Group type: COMPARATOR
Intervention: External stent
Number of subjects: 328
Study 27040594 — intervention group
Group type: EXPERIMENTAL
Intervention: Internal stent
Number of subjects: 328
Study 25187345 — intervention group
Group type: EXPERIMENTAL
Intervention: Radiofrequency (RF) turbinoplasty
Number of subjects: 90
Study 25187345 — intervention group
Group type: COMPARATOR
Intervention: Partial resection of the middle turbinate
Number of subjects: 90
Study 25187345 — intervention group
Group type: COMPARATOR
Intervention: Medialization of the middle turbinate by scarification to the septum
Number of subjects: 90
Study 23789288 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous omega-3 polyunsaturated fatty acids infusion
Number of subjects: 40
Study 23789288 — intervention group
Group type: COMPARATOR
Intervention: 0.9% saline solution infusion (Control)
Number of subjects: 40
Study 21368667 — intervention group
Group type: EXPERIMENTAL
Intervention: Leech therapy (2 to 4 locally applied leeches)
Number of subjects: 40
Study 21368667 — intervention group
Group type: COMPARATOR
Intervention: Topical diclofenac (30-day course)
Number of subjects: 40
Study 21368667 — intervention group
Group type: EXPERIMENTAL
Intervention: Leech therapy
Number of subjects: 40
Study 21368667 — intervention group
Group type: COMPARATOR
Intervention: Topical diclofenac
Number of subjects: 40
Study 17659263 — intervention group
Group type: EXPERIMENTAL
Intervention: 2 g of sarcosine daily
Number of subjects: 20
Study 17659263 — intervention group
Group type: EXPERIMENTAL
Intervention: 1 g of sarcosine daily
Number of subjects: 20
Study 17659263 — intervention group
Group type: EXPERIMENTAL
Intervention: Both doses of sarcosine
Number of subjects: 20
Study 16608764 — intervention group
Group type: EXPERIMENTAL
Intervention: Dynamic resistance training for 13 weeks (free-weight squat lift, concentric phase performed explosively)
Number of subjects: 30
Study 16608764 — intervention group
Group type: COMPARATOR
Intervention: Control group (no resistance training)
Number of subjects: 30
Study 10969521 — intervention group
Group type: EXPERIMENTAL
Intervention: i.v. tramadol (1 mg/kg)
Number of subjects: 40
Study 10969521 — intervention group
Group type: COMPARATOR
Intervention: Control group (no tramadol)
Number of subjects: 40
Study 8851611 — intervention group
Group type: EXPERIMENTAL
Intervention: Cefetamet pivoxil (500 mg)
Number of subjects: 27
Study 8851611 — intervention group
Group type: EXPERIMENTAL
Intervention: Cefuroxime axetil (125 mg and 250 mg)
Number of subjects: 27
Study 1519960 — intervention group
Group type: EXPERIMENTAL
Intervention: Ready-to-feed infant formula
Number of subjects: 43
Study 1519960 — intervention group
Group type: COMPARATOR
Intervention: Powdered infant formula
Number of subjects: 43
Study 1519960 — intervention group
Group type: COMPARATOR
Intervention: Breast fed infants
Number of subjects: 43
Study 6380356 — intervention group
Group type: EXPERIMENTAL
Intervention: Theophylline (therapeutic serum concentration averaged 13 mg/L, range 4.0 to 22.1)
Number of subjects: 8
Study 6380356 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 8
Study 30148969 — intervention group
Group type: EXPERIMENTAL
Intervention: 15% of 1-repetition maximum (1RM) without BFR (15/00)
Number of subjects: 97
Study 30148969 — intervention group
Group type: EXPERIMENTAL
Intervention: 15% 1RM with BFR at 40% of arterial occlusion pressure (AOP) (15/40)
Number of subjects: 97
Study 30148969 — intervention group
Group type: EXPERIMENTAL
Intervention: 15% of 1RM with BFR at 80% of AOP (15/80)
Number of subjects: 97
Study 30148969 — intervention group
Group type: EXPERIMENTAL
Intervention: 70% of 1RM without BFR (70/00)
Number of subjects: 97
Study 30160510 — intervention group
Group type: EXPERIMENTAL
Intervention: Targeted Training in Illness Management (TTIM)
Number of subjects: 0
Study 30160510 — intervention group
Group type: COMPARATOR
Intervention: Treatment as usual
Number of subjects: 0
Study 27401638 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensive lipid-lowering treatment (ezetimibe/simvastatin 10/40 mg, n=34)
Number of subjects: 70
Study 27401638 — intervention group
Group type: COMPARATOR
Intervention: Control statin treatment (pravastatin 20 mg, n=36)
Number of subjects: 70
Study 24169031 — intervention group
Group type: EXPERIMENTAL
Intervention: Beauty treatments during hospitalization
Number of subjects: 100